Hykes Andrew 4
4 · Inari Medical, Inc. · Filed Feb 12, 2025
Insider Transaction Report
Form 4
Hykes Andrew
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option
2025-02-10−16,719→ 0 totalExercise: $0.46Exp: 2029-03-12→ Common Stock (16,719 underlying) - Exercise/Conversion
Common Stock
2025-02-10$0.43/sh+161,100$69,015→ 663,806 total - Exercise/Conversion
Common Stock
2025-02-10$6.45/sh+16,719$107,914→ 680,525 total - Exercise/Conversion
Common Stock
2025-02-10$0.46/sh+16,719$7,639→ 697,244 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-02-10−161,100→ 0 totalExercise: $0.43Exp: 2028-05-03→ Common Stock (161,100 underlying) - Exercise/Conversion
Stock Option
2025-02-10−16,719→ 0 totalExercise: $6.45Exp: 2030-01-17→ Common Stock (16,719 underlying)
Holdings
- 1,550(indirect: By Children)
Common Stock
- 1,550(indirect: By Children)
Common Stock
- 1,550(indirect: By Children)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]The option became fully vested and exercisable as of March 29, 2022.
- [F2]The option became fully vested and exercisable as of January 1, 2024.
- [F3]The option became fully vested and exercisable as of January 1, 2023.